Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,504.70
+96.70 (4.02%)
Nov 4, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 706.83 billion as of November 4, 2026. It is the 2,705th most valuable company in the world and the 153rd biggest in India. Its market cap has increased by 31.94% in one year.
Market Cap
706.83B
Enterprise Value
701.00B
Revenue
177.37B
Global Rank
Country Rank
#153 India
PE Ratio
39.33
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 706.83B, an increase of 61,400.60%. That is a compound annual growth rate of 28.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 706.83B | 23.07% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.26T |
| Zydus Lifesciences | 1.24T |
| Cipla | 1.13T |
| Mankind Pharma | 1.02T |
| Aurobindo Pharma | 974.98B |
| Alkem Laboratories | 626.04B |
| Gland Pharma | 521.11B |
| Ipca Laboratories | 494.98B |